Composite tablet for treating stomach and intestines disease
The present invention relates to a composite tablet for treating gastrointestinal diseases, which comprises roxatidine acetate hydrochloride, bismuth citrate potassium, and sucralfate hydrate as active ingredients, and more preferably, to a composite tablet for treating gastrointestinal diseases, wh...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The present invention relates to a composite tablet for treating gastrointestinal diseases, which comprises roxatidine acetate hydrochloride, bismuth citrate potassium, and sucralfate hydrate as active ingredients, and more preferably, to a composite tablet for treating gastrointestinal diseases, which comprises a core tablet containing roxatidine acetate hydrochloride as an active ingredient, and an outer layer comprising bismuth citrate potassium and sucralfate hydrate as active ingredients. The present invention can eliminate side effects caused by nitroso dimethylamine, which is a carcinogen.
본 발명은 록사티딘 아세테이트 염산염과 비스무스 시트르산염 칼륨 및 수크랄페이트 수화물을 유효성분으로 포함하는 위장질환 치료용 복합정제에 관한 것으로, 좀더 바람직하기로는, 록사티딘 아세테이트 염산염을 유효성분으로 포함하는 핵정과, 비스무스 시트르산염 칼륨과 수크랄페이트 수화물을 유효성분으로 포함하는 외층을 포함하여 구성되는 위장질환 치료용 핵정 복합정제에 관한 것이다. |
|---|